X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (457) 457
Patent (40) 40
Publication (34) 34
Book / eBook (5) 5
Book Chapter (4) 4
Book Review (3) 3
Conference Proceeding (2) 2
Video Recording (2) 2
Dissertation (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (218) 218
oncology (156) 156
female (138) 138
male (137) 137
middle aged (132) 132
index medicus (127) 127
aged (115) 115
adult (107) 107
cancer (107) 107
chemotherapy (106) 106
treatment outcome (70) 70
colorectal cancer (67) 67
antineoplastic combined chemotherapy protocols - therapeutic use (61) 61
survival (55) 55
colorectal neoplasms - pathology (51) 51
metastasis (51) 51
surgery (51) 51
oxaliplatin (49) 49
fluorouracil - administration & dosage (45) 45
fluorouracil (44) 44
liver neoplasms - secondary (44) 44
colorectal neoplasms - drug therapy (42) 42
prognosis (41) 41
care and treatment (38) 38
hematology, oncology and palliative medicine (38) 38
organoplatinum compounds - administration & dosage (37) 37
tumors (37) 37
disease-free survival (36) 36
liver metastases (35) 35
carcinoma (33) 33
survival rate (33) 33
aged, 80 and over (32) 32
liver neoplasms - drug therapy (32) 32
gastroenterology & hepatology (31) 31
antineoplastic agents - therapeutic use (30) 30
retrospective studies (30) 30
irinotecan (29) 29
camptothecin - analogs & derivatives (27) 27
prospective studies (27) 27
antineoplastic combined chemotherapy protocols - adverse effects (26) 26
leucovorin - administration & dosage (26) 26
chemotherapy, adjuvant (24) 24
metastases (24) 24
neoplasm staging (24) 24
survival analysis (24) 24
5-fluorouracil (23) 23
cisplatin (23) 23
follow-up studies (23) 23
leucovorin (23) 23
liver neoplasms - surgery (23) 23
adenocarcinoma (22) 22
combined modality therapy (22) 22
life sciences (22) 22
medicine & public health (22) 22
neoplasm metastasis (22) 22
radiology, nuclear medicine & medical imaging (22) 22
camptothecin - administration & dosage (21) 21
cetuximab (21) 21
analysis (20) 20
antineoplastic combined chemotherapy protocols - administration & dosage (20) 20
colorectal-cancer (20) 20
therapy (19) 19
bevacizumab (18) 18
cleaning beaches (18) 18
cleaning of permanent ways (18) 18
clinical trials (18) 18
colorectal neoplasms - genetics (18) 18
construction of roads, railways, or bridges (18) 18
dispersing (18) 18
drug therapy (18) 18
fixed constructions (18) 18
fog in general (18) 18
gemcitabine (18) 18
management (18) 18
radiotherapy (18) 18
street cleaning (18) 18
1st-line treatment (17) 17
combination (17) 17
liver neoplasms - therapy (17) 17
pancreatic cancer (17) 17
patients (17) 17
research (17) 17
drug administration schedule (16) 16
liver cancer (16) 16
pancreatic neoplasms - drug therapy (16) 16
phase-iii trial (16) 16
time factors (16) 16
adenocarcinoma - drug therapy (15) 15
fluorouracil - adverse effects (15) 15
france (15) 15
health aspects (15) 15
hepatectomy (15) 15
phase-ii trial (15) 15
antineoplastic agents - administration & dosage (14) 14
cisplatin - administration & dosage (14) 14
diagnosis (14) 14
liver neoplasms - pathology (14) 14
multivariate analysis (14) 14
pancreatic neoplasms - pathology (14) 14
phase-ii (14) 14
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (395) 395
French (122) 122
German (11) 11
Spanish (3) 3
Norwegian (2) 2
Chinese (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 05/2011, Volume 364, Issue 19, pp. 1817 - 1825
In this study, a four-drug combination chemotherapy regimen was associated with objective responses in more than 30% of patients and increased survival by more... 
PHASE-III TRIAL | 5-FLUOROURACIL | MEDICINE, GENERAL & INTERNAL | SOLID TUMORS | CLINICAL-TRIALS | IRINOTECAN | OXALIPLATIN | 1ST-LINE THERAPY | COMBINATION | CARCINOMA | COOPERATIVE-ONCOLOGY-GROUP | Leucovorin - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Pancreatic Neoplasms - drug therapy | Deoxycytidine - therapeutic use | Organoplatinum Compounds - administration & dosage | Fluorouracil - administration & dosage | Neoplasm Metastasis - drug therapy | Adult | Camptothecin - administration & dosage | Deoxycytidine - adverse effects | Female | Pancreatic Neoplasms - mortality | Camptothecin - analogs & derivatives | Severity of Illness Index | Pancreatic Neoplasms - pathology | Proportional Hazards Models | Adenocarcinoma - drug therapy | Adenocarcinoma - secondary | Antimetabolites, Antineoplastic - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Antimetabolites, Antineoplastic - adverse effects | Survival Analysis | Quality of Life | Aged | Deoxycytidine - analogs & derivatives | Adenocarcinoma - mortality | Chemotherapy, Combination | Usage | Care and treatment | Gemcitabine | Pancreatic cancer | Leucovorin | Comparative analysis | Drug therapy | Fluorouracil | Clinical trials | Cytotoxicity | Pancreas | Patients | Index Medicus | Abridged Index Medicus
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2011, Volume 12, Issue 11, pp. 1032 - 1044
Journal Article
Annals of Oncology, ISSN 0923-7534, 10/2017, Volume 28, Issue suppl_9
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 4, pp. 426 - 428
Journal Article
European Journal of Cancer, ISSN 0959-8049, 05/2019, Volume 112, pp. 80 - 82
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2010, Volume 28, Issue 15, pp. 2556 - 2564
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 8, pp. 819 - 828
Summary Background Gemcitabine plus a platinum-based agent (eg, cisplatin or oxaliplatin) is the standard of care for advanced biliary cancers. We investigated... 
Hematology, Oncology and Palliative Medicine | GROWTH-FACTOR RECEPTOR | MULTICENTER | CISPLATIN | ONCOLOGY | COLORECTAL-CANCER | CLINICAL-TRIALS | GALLBLADDER | COMBINATION | TUMORS | CHEMOTHERAPY | GALL-BLADDER CANCER | ras Proteins - genetics | Peripheral Nervous System Diseases - chemically induced | Proto-Oncogene Proteins p21(ras) | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Alanine Transaminase - blood | Organoplatinum Compounds - administration & dosage | Antibodies, Monoclonal, Humanized - administration & dosage | Oxaliplatin | Common Bile Duct Neoplasms - drug therapy | Adult | Bile Ducts, Intrahepatic | Female | Bile Duct Neoplasms - genetics | Cetuximab | Neutropenia - chemically induced | Common Bile Duct Neoplasms - genetics | Bile Duct Neoplasms - drug therapy | Carcinoma - drug therapy | Antibodies, Monoclonal, Humanized - adverse effects | Deoxycytidine - administration & dosage | Gallbladder Neoplasms - genetics | Proto-Oncogene Proteins - genetics | Disease-Free Survival | Gallbladder Neoplasms - drug therapy | Aspartate Aminotransferases - blood | Cholangiocarcinoma - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Proto-Oncogene Proteins B-raf - genetics | Intention to Treat Analysis | Cholangiocarcinoma - genetics | Carcinoma - genetics | Aged | Mutation | Deoxycytidine - analogs & derivatives | Chemotherapy | Product development | Gemcitabine | Comparative analysis | Cancer
Journal Article
European Journal of Cancer, ISSN 0959-8049, 12/2016, Volume 69, p. 178
Ducreux and Pignon reflect on a meta-analysis based on aggregated data of the randomised trials comparing the efficacy of bevacizumab and anti-epidermal growth... 
Chemotherapy | Epidermal growth factor | Colorectal cancer | Clinical trials | Meta-analysis
Journal Article
by Emile, Jean-François and Julié, Catherine and Le Malicot, Karine and Lepage, Come and Tabernero, Josep and Mini, Enrico and Folprecht, Gunnar and Van Laethem, Jean-Luc and Dimet, Stéphanie and Boulagnon-Rombi, Camille and Allard, Marc-Antoine and Penault-Llorca, Frédérique and Bennouna, Jaafar and Laurent-Puig, Pierre and Taieb, Julien and Thaler, Josef and Greil, Richard and Gaenzer, Johannes and Eisterer, Wolfgang and Tschmelitsch, Joerg and Keil, Felix and Samonigg, Hellmut and Zabernigg, August and Schmid, Franz and Steger, Günther and Steinacher, Robert and Andel, Johannes and Jagdt, Björn and Lang, Alois and Fridrik, Michael and Függer, Reinhold and Hofbauer, Friedrich and Woell, Ewald and Geissler, Michael and Geissler, Dietmar and Lenauer, Alfred and Prager, Manfred and D'Haens, Geert and Demolin, Gauthier and Kerger, Joseph and Deboever, Guido and Ghillebert, Gilbert and Polus, Marc and Van Cutsem, Eric and Kalantari, Hassan Rezaie and Delaunoit, Thierry and Goeminne, Jean Charles and Peeters, Marc and Vergauwe, Philippe and Houbiers, Ghislain and Humblet, Yves and Janssens, Jos and Schrijvers, Dirk and Vanderstraeten, Erik and Vermorken, Jan and Van Daele, Daniel and Ferrante, Michel and Forget, Frederic and Hendlisz, Alain and Yilmaz, Mette and Nielsen, Svend Erik and Vestermark, Lene and Larsen, Jim and Zawadi, Mohamed-Ayman and Bouche, Olivier and Mineur, Laurent and Bennouna-Louridi, Jaafar and Dourthe, Louis Marie and Ychou, Marc and Boucher, Eveline and Pezet, Denis and Desseigne, Francoise and Ducreux, Michel and Texereau, Patrick and Miglianico, Laurent and Rougier, Philippe and Fratte, Serge and Levache, Charles-Briac and Merrouche, Yacine and Ellis, Stephen and Locher, Christophe and Ramee, Jean-Francois and Garnier, Claire and Viret, Frederic and Chauffert, Bruno and Cojean-Zelek, Isabelle and Michel, Pierre and Lecaille, Cedric and Borel, Christian and Seitz, Jean-Francois and Smith, Denis and Lombard-Bohas, Catherine and Andre, Thierry and Gornet, Jean-Marc and Fein, Francine and Coulon-Sfairi, Marie-Aude and Kaminsky, Marie-Christine and Lagasse, Jean-Paul and Luet, Dominique and Etienne, Pierre-Luc and ... and PETACC8 Study Investigators and Istituto Oncologico Romagnolo (IOR) and Fédération Nationale des Centres de Lutte Contre le Cancer Association Européenne de Recherche en Oncologie (AERO) and Gruppo Cooperativo do Cancro Digestivo da Associação Portuguesa de Investigação Oncológica (GCCD, APIO) and Lone Nørgård Petersen and Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente (GISCAD) and Austrian Breast and Colorectal cancer Study Group (ABCSG) and Belgian Group of Digestive Oncology (BGDO) and Gruppo Cooperativo Chirurgico Italiano (GOCCI) and John Allen Bridgewater and Gruppo Oncologico dell'Italia Meridionale (GOIM) and Fédération Francophone de Cancérologie Digestive (FFCD) and Gruppo Oncologico Nord Ovest (GONO) and Fédération Nationale des Centres de Lutte Contre le Cancer (UNICANCER) and Grupo Español para el Tratamiento de los Tumores Digestivos (TTD) and Arbeitsgemeinschaft Internistische Onkologie (AIO) and Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC)
European Journal of Cancer, ISSN 0959-8049, 09/2017, Volume 82, pp. 16 - 24
Journal Article